GridAI Technologies (GRDX) EBITDA (2015 - 2025)
GridAI Technologies' (GRDX) quarterly EBITDA came in at -$4.7 million in Q4 2025, down 289.56% YoY from $2.5 million in Q4 2024, and down 401.55% on a QoQ basis from -$934787.0 in Q3 2025.
GridAI Technologies (GRDX) EBITDA (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of EBITDA data on file, last reported at -$4.7 million in Q4 2025.
- Quarterly EBITDA fell 289.56% year-over-year to -$4.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.1 million (up 54.66% YoY) and the FY2025 annual result came in at -$7.1 million, up 54.66% from the prior year.
- EBITDA retreated to -$4.7 million in Q4 2025, from -$934787.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $4.4 million in Q3 2022 to a low of -$30.4 million in Q3 2021.
- A 5-year average of -$5.5 million and a median of -$4.1 million in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2021 — EBITDA tumbled 718.97% — and 2022, when it soared 114.44%.
- Tracing GRDX's EBITDA over 5 years: stood at -$11.2 million in 2021, then soared by 79.59% to -$2.3 million in 2022, then sank by 79.57% to -$4.1 million in 2023, then surged by 70.6% to -$1.2 million in 2024, then sank by 289.56% to -$4.7 million in 2025.
- The last three EBITDA figures came in at -$4.7 million (Q4 2025), -$934787.0 (Q3 2025), and -$638864.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | -4.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.69 Mn |
| Sep 30, 2025 | -934,787.00 |
| Jun 30, 2025 | -638,864.00 |
| Mar 31, 2025 | -821,386.00 |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -1.89 Mn |
| Jun 30, 2024 | -3.43 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -4.09 Mn |
| Sep 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -4.18 Mn |
| Mar 31, 2023 | -4.06 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | 4.39 Mn |
| Jun 30, 2022 | -5.41 Mn |
| Mar 31, 2022 | -9.38 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -30.40 Mn |
| Jun 30, 2021 | -9.28 Mn |
| Mar 31, 2021 | -8.21 Mn |